dihydroergotamine 5.2 MG Nasal Powder

RxCUI: 2714187
RxNorm name: dihydroergotamine 5.2 MG Nasal Powder
Display name: dihydroergotamine 5.2 MG Nasal Powder
Full name: dihydroergotamine 5.2 MG Nasal Powder
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ATZUMI	DIHYDROERGOTAMINE MESYLATE	Satsuma Pharmaceuticals, Inc.	0982a44a-dc0c-75c0-e063-6394a90a6d6c	2026-06-22	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2714187

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
0982a44a-dc0c-75c0-e063-6394a90a6d6c	dihydroergotamine 5.2 MG Nasal Powder	SCD	2	These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946	20250508
0982a44a-dc0c-75c0-e063-6394a90a6d6c	dihydroergotamine 5.2 MG (equivalent to dihydroergotamine mesylate 6 MG) Nasal Powder	SY	2	These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946	20250508
0982a44a-dc0c-75c0-e063-6394a90a6d6c	DHE 5.2 MG Nasal Powder	SY	2	These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946	20250508
0982a44a-dc0c-75c0-e063-6394a90a6d6c	dihydroergotamine 5.2 MG Nasal Powder	PSN	2	These highlights do not include all the information needed to use ATZUMI safely and effectively. See full prescribing information for ATZUMI. ATZUMI™ (dihydroergotamine) nasal powder Initial U.S. Approval: 1946	20250508